MBA Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$257K Hold
3,608
0.1% 129
2025
Q4
$296K Hold
3,608
0.12% 113
2025
Q3
$271K Sell
3,608
-12
-0.3% -$895 0.12% 117
2025
Q2
$268K Sell
3,620
-9
-0.2% -$627 0.12% 114
2025
Q1
$293K Buy
3,629
+21
+0.6% +$1.8K 0.15% 110
2024
Q4
$282K Hold
3,608
0.14% 109
2024
Q3
$339K Hold
3,608
0.16% 99
2024
Q2
$281K Sell
3,608
-16
-0.4% -$1.3K 0.14% 104
2024
Q1
$329K Hold
3,624
0.17% 95
2023
Q4
$280K Hold
3,624
0.16% 101
2023
Q3
$247K Hold
3,624
0.15% 100
2023
Q2
$294K Sell
3,624
-83
-2% -$6.62K 0.18% 93
2023
Q1
$304K Buy
+3,707
New +$265K 0.19% 97

Other funds holding GEHC

MBA Advisors's GEHC Position: Q1 2026 in Review

MBA Advisors held its GE HealthCare (GEHC) position steady in Q1 2026 at 3,608 shares worth $257K. The position accounts for 0.1% of the portfolio, ranked #129.

MBA Advisors first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $339K in Q3 2024. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • MBA Advisors held 3,608 shares of GE HealthCare worth $257K as of Q1 2026.
  • MBA Advisors left its GE HealthCare share count unchanged in Q1 2026.
  • GE HealthCare made up 0.1% of MBA Advisors's portfolio in Q1 2026, its #129 holding.
  • MBA Advisors first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • MBA Advisors's GE HealthCare position peaked at $339K in Q3 2024.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on MBA Advisors's 13F filing for Q1 2026, filed 20 Apr 2026.